Literature DB >> 9504682

Premalignant and malignant disease of the breast: the roles of the pathologist.

D L Page1, R A Jensen, J F Simpson.   

Abstract

This review targets the current role of the pathologist in the diagnosis and management of breast disease, a responsibility that evolved along with an increasingly complex approach to human breast cancer. We will focus on the three major areas of this responsibility: premalignancy, highlighting the atypical hyperplasias; the carcinomas in situ, highlighting low grade ductal carcinoma in situ; and the stratification and prognosis of invasive carcinomas. It will be evident that with the advent of an increasingly rich menu of treatment options, the challenge to identify an optimal categorization of breast cancer and its putative precursors is not static.

Entities:  

Mesh:

Year:  1998        PMID: 9504682

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.

Authors:  Philip S Crooke; Christina Justenhoven; Hiltrud Brauch; Sheila Dawling; Nady Roodi; Kathryn S P Higginbotham; W Dale Plummer; Peggy A Schuyler; Melinda E Sanders; David L Page; Jeffrey R Smith; William D Dupont; Fritz F Parl
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

Review 2.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 3.  Historical and epidemiologic background of human premalignant breast disease.

Authors:  D L Page; R A Jensen; J F Simpson; W D Dupont
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

4.  Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk.

Authors:  William D Dupont; Joan P Breyer; Kevin M Bradley; Peggy A Schuyler; W Dale Plummer; Melinda E Sanders; David L Page; Jeffrey R Smith
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

5.  Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

Authors:  A Elzagheid; T Kuopio; S Pyrhönen; Y Collan
Journal:  Diagn Pathol       Date:  2006-11-08       Impact factor: 2.644

6.  Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis.

Authors:  H M Verkooijen; P H Peeters; E Buskens; V C Koot; I H Borel Rinkes; W P Mali; T J van Vroonhoven
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

7.  The Chinese Herbal Formula Ruyan Neixiao Cream Inhibits Angiogenesis of Precancerous Breast Lesions via Regulation of Ras/Raf/MEK/ERK Signaling Pathway.

Authors:  Shujun Lin; Xuefeng Jiang; Guijuan Zhang; Xinqin Xiao; Xinyi Ma; Jieyan Wu; Dan Qiu; Xinyuan Li; Xianxin Yan; Min Ma
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.